NCT04557371View on ClinicalTrials.gov

A Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Facial Skin-care Formulations.

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 12, 2020

Primary Completion Date

December 22, 2020

Study Completion Date

December 22, 2020

Conditions
Skin Care
Interventions
OTHER

Serum

Participants will topically apply the serum to the face as per normal home use application in place of their current facial serum product.

OTHER

Lotion

Participants will topically apply lotion to the face as per normal home use application in place of their current facial lotion product.

OTHER

Cream

Participants will topically apply cream to the face as per normal home use application in place of their current facial cream product.

Trial Locations (1)

22869

GSK Investigational Site, Schenefeld

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT04557371 - A Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Facial Skin-care Formulations. | Biotech Hunter | Biotech Hunter